Balaxi Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 526.704 million compared to INR 123.106 million a year ago. Net income was INR 83.61 million compared to INR 14.582 million a year ago. Basic earnings per share from continuing operations was INR 8.36 compared to INR 1.46 a year ago. For the full year, total revenue was INR 2,335.605 million compared to INR 462.274 million a year ago. Net income was INR 381.374 million compared to INR 60.973 million a year ago. Basic earnings per share from continuing operations was INR 38.14 compared to INR 8.12 a year ago.